Fundraising Fox
Nerai
1 known investors
Find your way into Nerai
Sign up to see every warm intro you have to Nerai
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nerai team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.
Investors · 1
Kickfundlisted by KickfundBasel · $950K
How we know: Kickfund's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Nerai do?
- Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.
- Who are Nerai's investors?
- Nerai's investors include Kickfund.